We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.08B
AUM Growth
+$407M
Cap. Flow
+$226M
Cap. Flow %
4.45%
Top 10 Hldgs %
23.59%
Holding
154
New
18
Increased
54
Reduced
21
Closed
16

Top Buys

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$69.6M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$63M
3
MDB icon
MongoDB
MDB
+$59.3M
4
DV icon
DoubleVerify
DV
+$47.6M
5
FLYW icon
Flywire
FLYW
+$39.8M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$165M
2
DUOL icon
Duolingo
DUOL
+$33.1M
3
KURA icon
Kura Oncology
KURA
+$32.8M
4
COGT icon
Cogent Biosciences
COGT
+$30.6M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$25.8M

Sector Composition

Rank Sector Weight
1 Healthcare 38.81%
2 Technology 24%
3 Industrials 15.64%
4 Consumer Discretionary 5.21%
5 Utilities 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNG icon
26
Cheniere Energy
LNG
$54.1B
$67.2M 1.32%
404,882
-2,418
-0.6% -$367K
GLBE icon
27
Global E Online
GLBE
$6.7B
$67M 1.32%
2,503,371
+150,000
+6% +$4.27M
EXAS
28
DELISTED
Exact Sciences
EXAS
$60.7M 1.19%
1,867,365
+501,765
+37% +$20.7M
SPT icon
29
Sprout Social
SPT
$509M
$60.1M 1.18%
990,943
– –
HZNP
30
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$60.1M 1.18%
971,200
+901,400
+1,291% +$63M
HUBS icon
31
HubSpot
HUBS
$11.9B
$58M 1.14%
214,865
-1,868
-0.9% -$593K
MDB icon
32
MongoDB
MDB
$26.2B
$57.4M 1.13%
289,160
+203,160
+236% +$59.3M
APTV icon
33
Aptiv
APTV
$12.3B
$56.3M 1.11%
720,147
+447
+0.1% +$42.9K
CCI icon
34
Crown Castle
CCI
$33.4B
$54M 1.06%
373,912
+24,412
+7% +$4.18M
ENTG icon
35
Entegris
ENTG
$17.8B
$53.9M 1.06%
649,268
+2,638
+0.4% +$258K
DV icon
36
DoubleVerify
DV
$1.69B
$50.5M 0.99%
+1,847,144
New +$47.6M
CLDX icon
37
Celldex Therapeutics
CLDX
$3.02B
$50.4M 0.99%
1,791,800
+346,100
+24% +$10.6M
DHI icon
38
D.R. Horton
DHI
$40.7B
$48.9M 0.96%
726,643
-54,857
-7% -$4.04M
GNRC icon
39
Generac Holdings
GNRC
$11.3B
$48M 0.95%
269,700
– –
ENPH icon
40
Enphase Energy
ENPH
$4.94B
$45.2M 0.89%
163,000
– –
DDOG icon
41
Datadog
DDOG
$95.6B
$45.1M 0.89%
507,635
+1,016
+0.2% +$102K
A icon
42
Agilent Technologies
A
$39.2B
$43.5M 0.86%
358,200
– –
TREX icon
43
Trex
TREX
$4.56B
$43.5M 0.86%
990,000
– –
MPWR icon
44
Monolithic Power Systems
MPWR
$64.7B
$43.1M 0.85%
118,598
+750
+0.6% +$334K
COGT icon
45
Cogent Biosciences
COGT
$7.07B
$42.7M 0.84%
2,860,892
-2,234,108
-44% -$30.6M
COLL icon
46
Collegium Pharmaceutical
COLL
$1.17B
$42.1M 0.83%
2,629,593
– –
LRCX icon
47
Lam Research
LRCX
$373B
$41.6M 0.82%
1,136,730
+1,730
+0.2% +$77K
FLYW icon
48
Flywire
FLYW
$2.01B
$41.3M 0.81%
1,800,367
+1,667,446
+1,254% +$39.8M
ZNTL icon
49
Zentalis Pharmaceuticals
ZNTL
$350M
$40.3M 0.79%
1,861,000
+857,000
+85% +$23.4M
BEP icon
50
Brookfield Renewable
BEP
$9.9B
$38.7M 0.76%
1,236,000
– –
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Eventide Asset Management held 154 positions worth $5.08B, up 8.7% from $4.68B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $226M of net new capital in Q3 2022, opening 18 new positions and adding to 54 existing holdings. Its largest new stake was DoubleVerify: 1,847,144 shares worth $50.5M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Cogent Biosciences, an estimated $30.6M trimmed.

  • Eventide Asset Management's largest Q3 2022 buy was DoubleVerify: 1,847,144 shares worth $50.5M.
  • Eventide Asset Management added most to Doximity in Q3 2022, an estimated $69.6M increase.
  • Eventide Asset Management's biggest Q3 2022 reduction was Cogent Biosciences, cutting an estimated $30.6M.
  • Eventide Asset Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $165M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $5.08B portfolio in Q3 2022.
  • Eventide Asset Management opened 18 new positions and closed 16 in Q3 2022.
  • Eventide Asset Management's portfolio value rose 8.7% quarter-over-quarter to $5.08B.

Based on Eventide Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.